Urinary 8-iso-prostaglandin F2α as a marker of metabolic risks in the general Japanese population: The ROAD study

ROS Function in Redox Signaling and Oxidative Stress

(2014) Michael Schieber et al.   CURRENT BIOLOGY

Differential patterns of effects of age and sex on metabolic syndrome in Taiwan: Implication for the inadequate internal consistency of the current criteria

(2014) Tzu-Wei Wu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Reduced Blood Nrf-2 mRNA in Local Overweight Boys at Risk of Metabolic Complications: A Study in San Luis City, San Luis, Argentina

(2013) Lucas D. Santillán et al.   Metabolic Syndrome and Related Disorders

Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer

(2013) Morihiro Matsuda et al.   Obesity Research & Clinical Practice

Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals

(2012) Minjoo Kim et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study

(2012) N. Yoshimura et al.   OSTEOARTHRITIS AND CARTILAGE

Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome

(2012) Maarten Hulsmans et al.   PLoS One

Negatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patients

(2011) Jungo Urata et al.   HEART AND VESSELS

An Integrative Genomics Approach Identifies Activation of Thioredoxin/Thioredoxin Reductase-1-Mediated Oxidative Stress Defense Pathway and Inhibition of Angiogenesis in Obese Nondiabetic Human Subjects

(2011) Swapan K. Das et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Redox-regulating role of insulin: The essence of insulin effect

(2011) Xin Wang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates

(2010) Zhao Yan et al.   ANALYTICAL BIOCHEMISTRY

Using Glycosylated Hemoglobin to Define the Metabolic Syndrome in United States Adults

(2010) K. L. Ong et al.   DIABETES CARE

HbA1c for the Diagnosis of Diabetes and Prediabetes: Is It Time for a Mid-Course Correction?

(2010) Robert M. Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

F2-Isoprostanes and Adiposity in Older Adults

(2010) Alka M. Kanaya et al.   Obesity

Cellular signaling and NO production

(2010) Thomas Michel et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Using Isoprostanes as Biomarkers of Oxidative Stress: Some Rarely Considered Issues

(2009) Barry Halliwell et al.   ANTIOXIDANTS & REDOX SIGNALING

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy

(2009) L. Monnier et al.   DIABETOLOGIA

Cohort Profile: Research on Osteoarthritis/Osteoporosis Against Disability study

(2009) N. Yoshimura et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The Metabolic Syndrome and Its Traits as Risk Factors for Subclinical Atherosclerosis

(2009) Suzanne Holewijn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers

(2009) Maria Gabriela Valle Gottlieb et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Nuclear Factor NF- B Pathway in Inflammation

(2009) T. Lawrence   Cold Spring Harbor Perspectives in Biology

F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications

(2008) Samar Basu   ANTIOXIDANTS & REDOX SIGNALING

Effect of Aging on A1C Levels in Individuals Without Diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004

(2008) L. N. Pani et al.   DIABETES CARE

The Metabolic Syndrome

(2008) Marc-Andre Cornier et al.   ENDOCRINE REVIEWS

HDL is the major lipoprotein carrier of plasma F2-isoprostanes

(2008) Julie M. Proudfoot et al.   JOURNAL OF LIPID RESEARCH